Dynamics of anti-RBD (anti-receptor binding domain) levels in diabetes patients following the ChAdOx1 nCoV-19 vaccine (AZD1222) in the Thai population

Abstract The ChAdOx1 nCoV-19 vaccine (AZD1222) was used in Thailand during the early outbreak of coronavirus disease 2019 (COVID-19). A previous study showed a low immune response in diabetes patients after the first dose of the AZD1222 vaccine. Furthermore, humoral immune responses after the second...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Scientific Reports
المؤلفون الرئيسيون:	Supamas Sirisreetreerux, Thachanun Porntharukchareon, Bothamai Dechates, Vimonsri Rangsrisaeneepitak, Phonthip Therawit, Supanat Worawitchawong, Gaidganok Sornsamdang, Kamonwan Soonklang, Kriangkrai Tawinprai
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Nature Portfolio 2023-07-01
الوصول للمادة أونلاين:	https://doi.org/10.1038/s41598-023-39114-5